30–50 Maximum 75% of dose10–30 25–50% of dose (equivalent of 150 mg daily)
<10           : 25– 50% of dose (equivalent of 50–100 mg daily) – use with caution
DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
CAPD                :Not dialysed. Dose as in GFR <10 mL/min
HD                     :Not dialysed. Dose as in GFR <10 mL/min
HDF/high flux   :Unknown dialysability. Dose as in GFR <10 mL/min
CAV/VVHD      :Unknown dialysability. Dose as in GFR=10–30 mL/min
IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugs
Anti-arrhythmics: increased risk of ventricular arrhythmias with amiodarone – avoid concomitant use
Antibacterials: increased risk of ventricular arrhythmias with moxifloxacin – avoid concomitant use
Anti-epileptics: antagonism of anticonvulsant effect
Antimalarials: increased risk of convulsions with mefloquine; avoid concomitant use with artemether/lumefantrine
Ciclosporin: increased ciclosporin concentration (increased risk of toxicity)Digoxin: possibly increased concentration of digoxinLanthanum: absorption possibly reduced by lanthanum – give at least 2 hours apart
ADMINISTRATION
Reconstition
–
Route
Oral
Rate of Administration
–
Comments
–
OTHER INFORMATION
Take with a meal or a glass of milk Excretory patterns are not well characterised, but hydroxychloroquine and its metabolites are slowly excreted via the kidneysAttempt to avoid prolonged use in renal failureIn renal insufficiency, need more than annual eye examinationsDoses from Seyffart, probably not actually practical to give reduced dose so try giving longer dose intervals